A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby‐Arnon, Charles H. Yoon, Claire Margolais et al.|Cell|2018Cited by 1.5k
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumorsDiana Miao, Eliezer M. Van Allen, Claire A. Margolis et al.|Nature Genetics|2018Cited by 701
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinomaKevin Bi, Eliezer M. Van Allen, Meng Xiao He et al.|Cancer Cell|2021Cited by 624
A novel recurrent mutation in MITF predisposes to familial and sporadic melanomaSatoru Yokoyama, Kevin M. Brown, Susan L. Woods et al.|Nature|2011Cited by 474
<i>BCL2A1</i> is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibitionRizwan Haq, David E. Fisher|Proceedings of the National Academy of Sciences|2013Cited by 224